Role of hormones, genes, and environment in human cryptorchidism

Endocrine Reviews

Volumn 29, Issue 5, 2008, Pages 560-580

  Foresta, Carlo ^a   Zuccarello, Daniela ^a   Garolla, Andrea ^a   Ferlin, Alberto ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; HORMONE; MUELLERIAN INHIBITING FACTOR; RELAXIN LIKE FACTOR; TESTOSTERONE;

ATTRIBUTABLE RISK; CRYPTORCHISM; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC RISK; HUMAN; INCIDENCE; KLINEFELTER SYNDROME; MALE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SUBFERTILITY; TESTIS CANCER; TESTIS DESCENT;

CRYPTORCHIDISM; ENDOCRINE SYSTEM; HOMEOSTASIS; HUMANS; INFERTILITY, MALE; INSULIN; MALE; POLYMORPHISM, GENETIC; PROTEINS; RISK FACTORS; TESTICULAR NEOPLASMS;

EID: 49449083090     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2007-0042     Document Type: Review

References (233)

1. Virtanen HE, Bjerknes R, Cortes D, Jørgensen N, Rajpert-De Meyts E, Thorsson AV, Thorup J, Main KM 2007 Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr 96:611-616
2. Boisen KA, Kaleva M, Main KM, Virtanen HE, Haavisto AM, Schmidt IM, Chellakooty M, Damgaard IN, Mau C, Reunanen M, Skakkebaek NE, Toppari J 2004 Difference in prevalence of congenital cryptorchidism in infants between two Nordic countries. Lancet 363:1264-1269
3. Barthold JS, Gonzalez R 2003 The epidemiology of congenital cryptorchidism, testicular ascent and orchiopexy. J Urol 170:2396-2401
4. Scorer CG 1964 The descent of the testis. Arch Dis Child 39:605-609
5. Cortes D, Kjellberg EM, Breddam M, Thorup J 2008 The true incidence of cryptorchidism in Denmark. J Urol 179:314-318
6. 1992 Cryptorchidism: a prospective study of 7500 consecutive male births, 1984-8. John Radcliffe Hospital Cryptorchidism Study Group. Arch Dis Child 67:892-899
7. Virtanen HE, Toppari J 2008 Epidemiology and pathogenesis of cryptorchidism. Hum Reprod Update 14:49-58
8. 1986 Cryptorchidism: an apparent substantial increase since 1960. John Radcliffe Hospital Cryptorchidism Study Group. Br Med J 293:1401-1404
9. Chilvers C, Pike MC, Forman D, Fogelman K, Wadsworth ME 1984 Apparent doubling of frequency of undescended testis in England and Wales in 1962-81. Lancet 2:330-332
10. Skakkebaek NE, Rajpert-De Meyts E, Main KM 2001 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972-978
11. Ghirri P, Ciulli C, Vuerich M, Cuttano A, Faraoni M, Guerrini L, Spinelli C, Tognetti S, Boldrini A 2002 Incidence at birth and natural history of cryptorchidism: a study of 10,730 consecutive male infants. J Endocrinol Invest 25:709-715
12. Werdelin L, Nilsonne A 1999 The evolution of the scrotum and testicular descent in mammals: a phylogenetic view. J Theor Biol 196:61-72
13. Hutson JM, Hasthorpe S, Heyns CF 1997 Anatomical and functional aspects of testicular descent and cryptorchidism. Endocr Rev 18:259-280
14. Nef S, Parada LF 2000 Hormones in male sexual development. Genes Dev 14:3075-3086
15. Kaleva M, Toppari J 2003 Genetics and hormones in testicular descent. Hormones 2:211-216
16. Adham IM, Burkhardt E, Benahmed M, Engel W 1993 Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem 268:26668-26672
17. Nef S, Parada LF 1999 Cryptorchidism in mice mutant for Insl3. Nat Genet 22:295-299
18. Zimmermann S, Steding G, Emmen JM, Brinkmann AO, Nayernia K, Holstein AF, Engel W, Adham IM 1999 Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol 13:681-691
19. Overbeek PA, Gorlov IP, Sutherland RW, Houston JB, Harrison WR, Boettger-Tong HL, Bishop CE, Agoulnik AI 2001 A transgenic insertion causing cryptorchidism in mice. Genesis 30:26-35
20. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ 2002 Activation of orphan receptors by the hormone relaxin. Science 295:671-674
21. Kumagai J, Hsu SY, Matsumi H, Roh JS, Fu P, Wade JD, Bathgate RA, Hsueh AJ 2002 INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 277: 31283-31286
22. Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI 2003 GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol 17:2639-2646
23. Foresta C, Bettella A, Vinanzi C, Dabrilli P, Meriggiola MC, Garolla A, Ferlin A 2004 A novel circulating hormone of testis origin in humans. J Clin Endocrinol Metab 89:5952-5958
24. Bay K, Hartung S, Ivell R, Schumacher M, Jürgensen D, Jorgensen N, Holm M, Skakkebaek NE, Andersson AM 2005 Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J Clin Endocrinol Metab 90:3410-3418
25. Bay K, Matthiesson KL, McLachlan RI, Andersson AM 2006 The effects of gonadotropin suppression and selective replacement on insulin-like factor 3 secretion in normal adult men. J Clin Endocrinol Metab 91:1108-1111
26. Ferlin A, Arredi B, Zuccarello D, Garolla A, Selice R, Foresta C 2006 Paracrine and endocrine roles of insulin-like factor 3. J Endocrinol Invest 29:657-664
27. Ferlin A, Garolla A, Rigon F, Rasi Caldogno L, Lenzi A, Foresta C 2006 Changes in serum insulin-like factor 3 during normal male puberty. J Clin Endocrinol Metab 91:3426-3431
28. Kubota Y, Nef S, Farmer PJ, Temelcos C, Parada LF, Hutson JM 2001 Leydig insulin-like hormone, gubernacular development and testicular descent. J Urol 165:1673-1675
29. Gorlov IP, Kamat A, Bogatcheva NV, Jones E, Lamb DJ, Truong A, Bishop CE, McElreavey K, Agoulnik AI 2002 Mutations of the GREAT gene cause cryptorchidism. Hum Mol Genet 11:2309-2318
30. Adham IM, Steding G, Thamm T, Büllesbach EE, Schwabe C, Paprotta I, Engel W 2002 The overexpression of the Insl3 in female mice causes descent of the ovaries. Mol Endocrinol 16:244-252
31. Adham IM, Agoulnik AI 2004 Insulin-like 3 signalling in testicular descent. Int J Androl 27:257-265
32. Emmen JM, McLuskey A, Adham IM, Engel W, Grootegoed JA, Brinkmann AO 2000 Hormonal control of gubernaculum development during testis descent: gubernaculum outgrowth in vitro requires both insulin-like factor and androgen. Endocrinology 141:4720-4727
33. Smith KJ, Wade JD, Claasz AA, Otvos Jr L, Temelcos C, Kubota Y, Hutson JM, Tregear GW, Bathgate RA 2001 Chemical synthesis and biological activity of rat INSL3. J Pept Sci 7:495-501
34. Kubota Y, Temelcos C, Bathgate RA, Smith KJ, Scott D, Zhao C, Hutson JM 2002 The role of insulin 3, testosterone, Mullerian inhibiting substance and relaxin in rat gubernacular growth. Mol Hum Reprod 8:900-905
35. Feng S, Bogatcheva NV, Truong A, Korchin B, Bishop CE, Klonisch T, Agoulnik IU, Agoulnik AI 2007 Developmental expression and gene regulation of insulin-like 3 receptor RXFP2 in mouse male reproductive organs. Biol Reprod 77:671-680
36. Virtanen HE, Cortes D, Rajpert-De Meyts E, Ritzén EM, Nordenskjöld A, Skakkebaek NE, Toppari J 2007 Development and descent of the testis in relation to cryptorchidism. Acta Paediatr 96:622-627
37. Yuan FP, Lin DX, Rao CV, Lei ZM 2006 Cryptorchidism in LhrKO animals and the effect of testosterone-replacement therapy. Hum Reprod 21:936-942
38. Feng S, Bogatcheva NV, Truong A, Engel W, Adham IM, Agoulnik AI 2006 Over expression of insulin-like 3 does not prevent cryptorchidism in GNRHR or HOXA10 deficient mice. J Urol 176:399-404
39. Zimmermann S, Schottler P, Engel W, Adham IM 1997 Mouse Leydig insulin-like (Ley I-L) gene: structure and expression during testis and ovary development. Mol Reprod Dev 47:30-38
40. Adham IM, Emmen JM, Engel W 2000 The role of the testicular factor INSL3 in establishing the gonadal position. Mol Cell Endocrinol 160:11-16
41. Balvers M, Spiess AN, Domagalski R, Hunt N, Kilic E, Mukhopadhyay AK, Hanks E, Charlton HM, Ivell R 1998 Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary. Endocrinology 139:2960-2970
42. O'Shaughnessy PJ, Willerton L, Baker PJ 2002 Changes in Leydig cell gene expression during development in the mouse. Biol Reprod 66:966-975
43. Spiess AN, Balvers M, Tena-Sempere M, Huhtaniemi I, Parry L, Ivell R 1999 Structure and expression of the rat relaxin-like factor (RLF) gene. Mol Reprod Dev 54:319-325
44. Boockfor FR, Fullbright G, Bullesbach EE, Schwabe C 2001 Relaxin-like factor (RLF) serum concentrations and gubernaculum RLF receptor display in relation to pre- and neonatal development of rats. Reproduction 122:899-906
45. Bay K, Virtanen HE, Hartung S, Ivell R, Main KM, Skakkebaek NE, Andersson AM; Nordic Cryptorchidism Study Group, Toppari J 2007 Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism. J Clin Endocrinol Metab 92:4020-4027
46. Wikström AM, Bay K, Hero M, Andersson AM, Dunkel L 2006 Serum insulin-like factor 3 levels during puberty in healthy boys and boys with Klinefelter syndrome. J Clin Endocrinol Metab 91:4705-4708
47. Anand-Ivell R, Wohlgemuth J, Haren MT, Hope PJ, Hatzinikolas G, Wittert G, Ivell R 2006 Peripheral INSL3 concentrations decline with age in a large population of Australian men. Int J Androl 29:618-626
48. Stillman RJ 1982 In utero exposure to diethylstilbestrol: adverse effects on the reproductive tract and reproductive performance and male and female offspring. Am J Obstet Gynecol 142:905-921
49. Emmen JM, McLuskey A, Adham IM, Engel W, Verhoef-Post M, Themmen AP, Grootegoed JA, Brinkmann AO 2000 Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism. Endocrinology 141:846-849
50. Nef S, Shipman T, Parada LF 2000 A molecular basis for estrogen-induced cryptorchidism. Dev Biol 224:354-361
51. Pitteloud N, Hayes FJ, Boepple PA, DeCruz S, Seminara SB, MacLaughlin DT, Crowley Jr WF 2002 The role of prior pubertal development, biochemical markers of testicular maturation, and genetics in elucidating the phenotypic heterogeneity of idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 87:152-160
52. Giannopoulos MF, Vlachakis IG, Charissis GC 2001 13 Years' experience with the combined hormonal therapy of cryptorchidism. Horm Res 55:33-37
53. Brinkmann AO 2001 Molecular basis of androgen insensitivity. Mol Cell Endocrinol 179:105-109
54. Sultan C, Paris F, Terouanne B, Balaguer P, Georget V, Poujol N, Jeandel C, Lumbroso S, Nicolas JC 2001 Disorders linked to insufficient androgen action in male children. Hum Reprod Update 7:314-322
55. Ferlin A, Vinanzi C, Garolla A, Selice R, Zuccarello D, Cazzadore C, Foresta C 2006d Male infertility and androgen receptor gene mutations: clinical features and identification of seven novel mutations. Clin Endocrinol (Oxf) 65:606-610
56. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321
57. Huhtaniemi I, Alevizaki M 2006 Gonadotrophin resistance. Best Pract Res Clin Endocrinol Metab 20:561-576
58. Hutson JM 1986 Testicular feminization: a model for testicular descent in mice and men. J Pediatr Surg 21:195-198
59. van der Schoot P, Emmen JM 1996 Development, structure and function of the cranial suspensory ligaments of the mammalian gonads in a cross-species perspective; their possible role in effecting disturbed testicular descent. Hum Reprod Update 2:399-418
60. Charlton HM, Halpin DM, Iddon C, Rosie R, Levy G, McDowell IF, Megson A, Morris JF, Bramwell A, Speight A, Ward BJ, Broadhead J, Davey-Smith G, Fink G 1983 The effects of daily administration of single and multiple injections of gonadotropin-releasing hormone on pituitary and gonadal function in the hypogonadal (hpg) mouse. Endocrinology 113:535-544
61. Mason AJ, Pitts SL, Nikolics K, Szonyi E, Wilcox JN, Seeburg PH, Stewart TA 1986 The hypogonadal mouse: reproductive functions restored by gene therapy. Science 234:1372-1378
62. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I 2001 Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol 15:172-183
63. Pask AJ, Kanasaki H, Kaiser UB, Conn PM, Janovick JA, Stockton DW, Hess DL, Justice MJ, Behringer RR 2005 A novel mouse model of hypogonadotrophic hypogonadism: N-ethyl-N-nitrosourea-induced gonadotropin-releasing hormone receptor gene mutation. Mol Endocrinol 19:972-981
64. McMahon DR, Kramer SA, Husmann DA 1995 Antiandrogen induced cryptorchidism in the pig is associated with failed gubernacular regression and epididymal malformations. J Urol 154:553-557
65. Bentvelsen FM, McPhaul MJ, Wilson JD, George FW 1994 The androgen receptor of the urogenital tract of the fetal rat is regulated by androgen. Mol Cell Endocrinol 105:21-26
66. Vigueras RM, Reyes G, Moreno-Mendoza N, Merchant-Larios H 2004 Gubernacular fibroblasts express the androgen receptor during testis descent in cryptorchid rats treated with human chorionic gonadotrophin. Urol Res 32:386-390
67. Cain MP, Kramer SA, Tindall DJ, Husmann DA 1995 Flutamide-induced cryptorchidism in the rat is associated with altered gubernacular morphology. Urology 46:553-558
68. Husmann DA, McPhaul MJ 1991 Time-specific androgen blockade with flutamide inhibits testicular descent in the rat. Endocrinology 129:1409-1416
69. Kassim NM, McDonald SW, Reid O, Bennett NK, Gilmore DP, Payne AP 1997 The effects of pre- and postnatal exposure to the nonsteroidal antiandrogen flutamide on testis descent and morphology in the Albino Swiss rat. J Anat 190:577-588
70. Spencer JR, Torrado T, Sanchez RS, Vaughan Jr ED, Imperato-McGinley J 1991 Effects of flutamide and finasteride on rat testicular descent. Endocrinology 129:741-748
71. Josso N, di Clemente N, Gouedard L 2001 Anti-Mullerian hormone and its receptors. Mol Cell Endocrinol 179:25-32
72. Lee MM, Donahoe PK 1993 Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14:152-164
73. Guerrier D, Tran D, Vanderwinden JM, Hideux S, Van Outryve L, Legeai L, Bouchard M, Van Vliet G, De Laet MH, Picard JY 1989 The persistent Müllerian duct syndrome: a molecular approach. J Clin Endocrinol Metab 68:46-52
74. Behringer RR, Finegold MJ, Cate RL 1994 Müllerian-inhibiting substance function during mammalian sexual development. Cell 79:415-425
75. Bartlett JE, Lee SM, Mishina Y, Behringer RR, Yang N, Wolf J, Temelcos C, Hutson JM 2002 Gubernacular development in Mullerian inhibiting substance receptor-deficient mice. Br J Urol Int 89:113-118
76. Mishina Y, Rey R, Finegold MJ, Matzuk MM, Josso N, Cate RL, Behringer RR 1996 Genetic analysis of the Müllerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10:2577-2587
77. Tran D, Picard JY, Vigier B, Berger R, Josso N 1986 Persistence of müllerian ducts in male rabbits passively immunized against bovine anti-müllerian hormone during fetal life. Dev Biol 116:160-167
78. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM 1983 Production of a novel neuropeptide encoded by the calcitonin gene via tissue specific RNA processing. Nature 304:129-135
79. Terada M, Goh DW, Farmer PJ, Hutson JM 1994 Ontogeny of gubernacular contraction and effect of calcitonin gene-related peptide in the mouse. J Pediatr Surg 29:609-611
80. Yamanaka J, Metcalfe SA, Hutson JM 1992 Demonstration of calcitonin gene-related peptide receptors in the gubernaculum by computerized densitometry. J Pediatr Surg 27:876-978
81. Hutson JM, Hasthorpe S 2005 Testicular descent and cryptorchidism: the state of the art in 2004. J Pediatr Surg 40:297-302
82. Hrabovszky Z, Farmer PJ, Hutson JM 2000 Does the sensory nucleus of the genitofemoral nerve have a role in testicular descent? J Pediatr Surg 35:96-100
83. Ng SL, Bidarkar SS, Sourial M, Farmer PJ, Donath S, Hutson JM 2005 Gubernacular cell division in different rodent models of cryptorchidism supports indirect androgenic action via the genitofemoral nerve. J Pediatr Surg 40:434-441
84. Lewis LG 1948 Cryptorchidism. J Urol 60:345-356
85. Park WH, Hutson JM 1991 The gubernaculum shows rhythmic contractility and active movement during testicular descent. J Pediatr Surg 26:615-617
86. Momose Y, Griffiths AL, Hutson JM 1992 Testicular descent III. The neonatal mouse gubernaculum shows rhythmic contraction in organ culture in response to calcitonin gene related peptide. Endocrinology 131:2881-2884
87. Goh DW, Momose Y, Middlesworth W, Hutson JM 1993 The relationship among calcitonin gene-related peptide, androgens and gubernacular development in 3 animal models of cryptorchidism. J Urol 150:574-576
88. Hrabovszky Z, Hutson JM 1999 Capsaicin restores gubernacular contractility in TS rats. J Pediatr Surg 34:1769-1772
89. Foresta C, Ferlin A, Garolla A, Milani C, Oliva G, Rossato M 1996 Functional and cytologic features of the contralateral testis in cryptorchidism. Fertil Steril 66:624-629
90. Giwercman A, von der Maase H, Skakkebaek NE 1993 Epidemiological and clinical aspects of carcinoma in situ of the testis. Eur Urol 23:104-110
91. Weidner IS, Møller H, Jensen TK, Skakkebaek NE 1999 Risk factors for cryptorchidism and hypospadias. J Urol 161:1606-1609
92. Czeizel A, Erödi E, Tóth J 1981 Genetics of undescended testis. J Urol 126:528-529
93. Elert A, Jahn K, Heidenreich A, Hofmann R 2003 The familial undescended testis. Klin Padiatr 215:40-45
94. Satokata I, Benson G, Maas R 1995 Sexually dimorphic sterility phenotypes in Hoxa 10-deficient mice. Nature 374:460-463
95. Hsieh-Li HM, Witte DP, Weinstein M, Branford W, Li H, Small K, Potter SS 1995 Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility. Development 121:1373-1385
96. Li X, Nokkala E, Yan W, Streng T, Saarinen N, Wärri A, Huhtaniemi I, Santti R, Mäkelä S, Poutanen M 2001 Altered structure and function of reproductive organs in transgenic male mice overexpressing human aromatase. Endocrinology 142:2435-2442
97. Radovick S, Wray S, Lee E, Nicols DK, Nakayama Y, Weintraub BD, Westphal H, Cutler Jr GB, Wondisford FE 1991 Migratory arrest of gonadotropin-releasing hormone neurons in transgenic mice. Proc Natl Acad Sci USA 88:3402-3406
98. Zhou X, Benson KF, Ashar HR, Chada K 1995 Mutation responsible for the mouse pygmy phenotype in the developmentally regulated factor HMGI-C. Nature 376:771-774
99. Lahoud MH, Ristevski S, Venter DJ, Jermiin LS, Bertoncello I, Zavarsek S, Hasthorpe S, Drago J, de Kretser D, Hertzog PJ, Kola I 2001 Gene targeting of Desrt, a novel ARID class DNA-binding protein, causes growth retardation and abnormal development of reproductive organs. Genome Res 11:1327-1334
100. Ikadai H, Ajisawa C, Taya K, Imamichi T 1988 Suprainguinal ectopic scrota of TS inbred rats. J Reprod Fertil 84:701-707
101. Klonisch T, Fowler PA, Hombach-Klonisch S 2004 Molecular and genetic regulation of testis descent and external genitalia development. Dev Biol 270:1-18
102. Koskimies P, Virtanen H, Lindstrom M, Kaleva M, Poutanen M, Huhtaniemi I, Toppari J 2000 A common polymorphism in the human relaxin-like factor (RLF) gene: no relationship with cryptorchidism. Pediatr Res 47:538-541
103. Krausz C, Quintana-Murci L, Fellous M, Siffroi JP, McElreavey K 2000 Absence of mutations involving the INSL3 gene in human idiopathic cryptorchidism. Mol Hum Reprod 6:298-302
104. Tomboc M, Lee PA, Mitwally MF, Schneck FX, Bellinger M, Witchel SF 2000 Insulin-like 3/relaxin-like factor gene mutations are associated with cryptorchidism. J Clin Endocrinol Metab 85:4013-4018
105. Lim HN, Raipert-de Meyts E, Skakkebaek NE, Hawkins JR, Hughes IA 2001 Genetic analysis of the INSL3 gene in patients with maldescent of the testis. Eur J Endocrinol 144:129-137
106. Marin P, Ferlin A, Moro E, Garolla A, Foresta C 2001 Different insulin-like 3 (INSL3) gene mutations not associated with human cryptorchidism. J Endocrinol Invest 24:RC13-RC15
107. Marin P, Ferlin A, Moro E, Rossi A, Bartoloni L, Rossato M, Foresta C 2001 Novel insulin-like 3 (INSL3) gene mutation associated with human cryptorchidism. Am J Med Genet 103:348-349
108. Takahashi I, Takahashi T, Komatsu M, Matsuda J, Takada G 2001 Ala/Thr60 variant of the Leydig insulin-like hormone is not associated with cryptorchidism in the Japanese population. Pediatr Int 43:256-258
109. Baker LA, Nef S, Nguyen MT, Stapleton R, Nordenskjold A, Pohl H, Parada LF 2002 The insulin-3 gene: lack of a genetic basis for human cryptorchidism. J Urol 167:2534-2537
110. Canto P, Escudero I, Soderlund D, Nishimura E, Carranza-Lira S, Gutierrez J, Nava A, Mendez JP 2003 A novel mutation of the insulin-like 3 gene in patients with cryptorchidism. J Hum Genet 48:86-90
111. Ferlin A, Simonato M, Bartoloni L, Rizzo G, Bettella A, Dottorini T, Dallapiccola B, Foresta C 2003 The INSL3-LGR8/GREAT ligand-receptor pair in human cryptorchidism. J Clin Endocrinol Metab 88:4273-4279
112. Roh J, Virtanen H, Kumagai J, Sudo S, Kaleva M, Toppari J, Hsueh AJ 2003 Lack of LGR8 gene mutation in Finnish patients with a family history of cryptorchidism. Reprod Biomed Online 7:400-406
113. Feng S, Cortessis VK, Hwang A, Hardy B, Koh CJ, Bogatcheva NV, Agoulnik AI 2004 Mutation analysis of INSL3 and GREAT/LGR8 genes in familial cryptorchidism. Urology 64:1032-1036
114. Foresta C, Ferlin A 2004 Role of INSL3 and LGR8 in cryptorchidism and testicular functions. Reprod Biomed Online 9:294-298
115. Ferlin A, Bogatcheva NV, Gianesello L, Pepe A, Vinanzi C, Agoulnik AI, Foresta C 2006 Insulin-like factor 3 gene mutations in testicular dysgenesis syndrome: clinical and functional characterization. Mol Hum Reprod 12:401-406
116. El Houate B, Rouba H, Sibai H, Barakat A, Chafik A, Chadli el B, Imken L, Bogatcheva NV, Feng S, Agoulnik AI, McElreavey K 2007 Novel mutations involving the INSL3 gene associated with cryptorchidism. J Urol 177:1947-1951
117. Yamazawa K, Wada Y, Sasagawa I, Aoki K, Ueoka K, Ogata T 2007 Mutation and polymorphism analyses of INSL3 and LGR8/GREAT in 62 Japanese patients with cryptorchidism. Horm Res 67:73-76
118. Bogatcheva NV, Ferlin A, Feng S, Truong A, Gianesello L, Foresta C, Agoulnik AI 2007 T222P mutation of the insulin-like 3 hormone receptor LGR8 is associated with testicular maldescent and hinders receptor expression on the cell surface membrane. Am J Physiol Endocrinol Metab 292:E138-E144
119. Ivell R, Bathgate RA 2002 Reproductive biology of the relaxin-like factor (RLF/INSL3). Biol Reprod 67:699-705
120. Nguyen MT, Showalter PR, Timmons CF, Nef S, Parada LF, Baker LA 2002 Effects of orchiopexy on congenitally cryptorchid insulin-3 knockout mice. J Urol 168:1779-1783
121. Boehmer AL, Brinkmann O, Bruggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, Niermeijer MF, Brunner HG, Rouwé CW, Waelkens JJ, Oostdijk W, Kleijer WJ, van der Kwast TH, de Vroede MA, Drop SL 2001 Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86:4151-4160
122. Barthold JS, Kumasi-Rivers K, Upadhyay J, Shekarriz B, Imperato-Mcginley J 2000 Testicular position in the androgen insensitivity syndrome: implications for the role of androgens in testicular descent. J Urol 164:497-501
123. Wiener JS, Marcelli M, Gonzales Jr ET, Roth DR, Lamb DJ 1998 Androgen receptor gene alterations are not associated with isolated cryptorchidism. J Urol 160:863-865
124. Suzuki Y, Sasagawa I, Ashida J, Nakada T, Muroya K, Ogata T 2001 Screening for mutations of the androgen receptor gene in patients with isolated cryptorchidism. Fertil Steril 76:834-836
125. Chamberlain NL, Driver ED, Miesfeld RL 1994 The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186
126. Choong CS, Kemppainen JA, Zhou ZX, Wilson EM 1996 Reduced androgen receptor gene expression with first exon CAG repeat expansion. Mol Endocrinol 10:1527-1535
127. Brooks BP, Fischbeck KH 1995 Spinal and bulbar muscular atrophy: a trinucleotide-repeat expansion neurodegenerative disease. Trends Neurosci 18:459-461
128. Kazemi-Esfarjani P, Trifiro MA, Pinsky L 1995 Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies. Hum Mol Genet 4:523-527
129. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH1991 Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
130. von Eckardstein S, Syska A, Gromoll J, Kamischke A, Simoni M, Nieschlag E 2001 Inverse correlation between sperm concentration and number of androgen receptor CAG repeats in normal men. J Clin Endocrinol Metab 86:2585-2590
131. Ferlin A, Raicu F, Gatta V, Zuccarello D, Palka G, Foresta C 2007 Male infertility: role of genetic background. Reprod Biomed Online 14:734-745
132. Sasagawa I, Suzuki Y, Tateno T, Nakada T, Muroya K, Ogata T 2000 CAG repeat length of the androgen receptor gene in Japanese males with cryptorchidism. Mol Hum Reprod 6:973-975
133. Lim HN, Nixon RM, Chen H, Hughes IA, Hawkins JR 2001 Evidence that longer androgen receptor polyglutamine repeats are a causal factor for genital abnormalities. J Clin Endocrinol Metab 86:3207-3210
134. Aschim EL, Nordenskjold A, Giwercman A, Lundin KB, Ruhayel Y, Haugen TB, Grotmol T, Giwercman YL 2004 Linkage between cryptorchidism, hypospadias, and GGN repeat length in the androgen receptor gene. J Clin Endocrinol Metab 89:5105-5109
135. Ferlin A, Garolla A, Bettella A, Bartoloni L, Vinanzi C, Roverato A, Foresta C 2005 Androgen receptor gene CAG and GGC repeat lengths in cryptorchidism. Eur J Endocrinol 152:419-425
136. Radpour R, Rezaee M, Tavasoly A, Solati S, Saleki A 2007 Association of long polyglycine tracts (GGN repeats) in exon 1 of the androgen receptor gene with cryptorchidism and penile hypospadias in Iranian patients. J Androl 28:164-169
137. Silva-Ramos M, Oliveira JM, Cabeda JM, Reis A, Soares J, Pimenta A 2006 The CAG repeat within the androgen receptor gene and its relationship to cryptorchidism. Int Braz J Urol 32:330-334
138. Toppari J, Virtanen H, Skakkebaek NE, Main KM 2006 Environmental effects on hormonal regulation of testicular descent. J Steroid Biochem Mol Biol 102:184-186
139. Foresta C, Moro E, Ferlin A 2001 Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev 22:226-239
140. Ferlin A, Arredi B, Speltra E, Cazzadore C, Selice R, Garolla A, Lenzi A, Foresta C 2007 Molecular and clinical characterization of Y chromosome microdeletions in infertile men: a 10-year experience in Italy. J Clin Endocrinol Metab 92:762-770
141. Vogt PH, Edelmann A, Kirsch S, Henegariu O, Hirschmann P, Kiesewetter F, Köhn FM, Schill WB, Farah S, Ramos C, Hartmann M, Hartschuh W, Meschede D, Behre HM, Castel A, Nieschlag E, Weidner W, Gröne HJ, Jung A, Engel W, Haidl G 1996 Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 5:933-943
142. Kuroda-Kawaguchi T, Skaletsky H, Brown LG, Minx PJ, Cordum HS, Waterston RH, Wilson RK, Silber S, Oates R, Rozen S, Page DC 2001 The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet 29:279-286
143. Repping S, Skaletsky H, Lange J, Silber S, Van Der Veen F, Oates RD, Page DC, Rozen S 2002 Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 71:906-922
144. Skaletsky H, Kuroda-Kawaguchi T, Minx PJ, Cordum HS, Hillier L, Brown LG, Repping S, Pyntikova T, Ali J, Bieri T, Chinwalla A, Delehaunty A, Delehaunty K, DuH, Fewell G, Fulton L, Fulton R, Graves T, Hou SF, Latrielle P, Leonard S, Mardis E, Maupin R, McPherson J, Miner T, Nash W, Nguyen C, Ozersky P, Pepin K, Rock S, Rohlfing T, Scott K, Schultz B, Strong C, Tin-Wollam A, Yang SP, Waterston RH, Wilson RK, Rozen S, Page DC 2003 The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423:825-837
145. Repping S, Skaletsky H, Brown L, van Daalen SK, Korver CM, Pyntikova T, Kuroda-Kawaguchi T, de Vries JW, Oates RD, Silber S, van der Veen F, Page DC, Rozen S 2003 Polymorphism for a 1.6-Mb deletion of the human Y chromosome persists through balance between recurrent mutation and haploid selection. Nat Genet 35:247-251
146. Tüttelmann F, Rajpert-De Meyts E, Nieschlag E, Simoni M 2007 Gene polymorphisms and male infertility - a meta-analysis and literature review. Reprod Biomed Online 15:643-658
147. Foresta C, Moro E, Garolla A, Onisto M, Ferlin A 1999 Y chromosome microdeletions in cryptorchidism and idiopathic infertility. J Clin Endocrinol Metab 84:3660-3665
148. Ferlin A, Bettella A, Tessari A, Salata E, Dallapiccola B, Foresta C 2004 Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. Fertil Steril 81:1013-1018
149. Kunej T, Zorn B, Peterlin B 2003 Y chromosome microdeletions in infertile men with cryptorchidism. Fertil Steril 79(Suppl 3):1559-1565
150. Dada R, Gupta NP, Kucheria K 2002 AZF microdeletions associated with idiopathic and non-idiopathic cases with cryptorchidism and varicocele. Asian J Androl 4:259-263
151. Song NH, Wu HF, Zhang W, Zhuo ZM, Qian LX, Hua LX, Guo L, Feng NH 2005 Screening for Y chromosome microdeletions in idiopathic and nonidiopathic infertile men with varicocele and cryptorchidism. Chin Med J (Engl) 118:1462-1467
152. Bor P, Hindkjaer J, Kølvraa S, Rossen P, von der Maase H, Jørgensen TM, Sørensen VT, Eiberg H, Ingerslev HJ 2006 Screening for Y microdeletions in men with testicular cancer and undescended testis. J Assist Reprod Genet 23:41-45
153. Giachini C, Nuti F, Marinari E, Forti G, Krausz C 2007 Partial AZFc deletions in infertile men with cryptorchidism. Hum Reprod 22:2398-2403
154. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette Jr LJ, Jégou B, Jensen TK, Jouannet P, Keiding N, Leffers H, McLachlan JA, Meyer O, Múller J, Rajpert-De Meyts E, Scheike T, Sharpe R, Sumpter J, Skakkebaek NE 1996 Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104(Suppl 4):741-803
155. Olesen IA, Sonne SB, Hoei-Hansen CE, Rajpert-DeMeyts E, Skakkebaek NE 2007 Environment, testicular dysgenesis and carcinoma in situ testis. Best Pract Res Clin Endocrinol Metab 21:462-478
156. McLachlan JA 2001 Environmental signaling: what embryos and evolution teach us about endocrine disrupting chemicals. Endocr Rev 22:319-341
157. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS 1994 Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 331:1056-1061
158. O'Donnell L, Robertson KM, Jones ME, Simpson ER 2001 Estrogen and spermatogenesis. Endocr Rev 22:289-318
159. Donaldson KM, Tong SY, Washburn T, Lubahn DB, Eddy EM, Hutson JM, Korach KS 1996 Morphometric study of the gubernaculum in male estrogen receptor mutant mice. J Androl 17:91-95
160. Yoshida R, Fukami M, Sasagawa I, Hasegawa T, Kamatani N, Ogata T 2005 Association of cryptorchidism with a specific haplotype of the estrogen receptor α gene: implication for the susceptibility to estrogenic environmental endocrine disruptors. J Clin Endocrinol Metab 90:4716-4721
161. Galan JJ, Guarducci E, Nuti F, Gonzalez A, Ruiz M, Ruiz A, Krausz C 2007 Molecular analysis of estrogen receptor α gene AGATA haplotype and SNP12 in European populations: potential protective effect for cryptorchidism and lack of association with male infertility. Hum Reprod 22:444-449
162. Aschim EL, Giwercman A, Ståhl O, Eberhard J, Cwikiel M, Nordenskjöld A, Haugen TB, Grotmol T, Giwercman YL 2005 The RsaI polymorphism in the estrogen receptor-β gene is associated with male infertility. J Clin Endocrinol Metab 90:5343-5348
163. Zuccarello D, Morini E, Douzgou S, Ferlin A, Pizzuti A, Salpietro DC, Foresta C, Dallapiccola B 2004 Preliminary data suggest that mutations in the CgRP pathway are not involved in human sporadic cryptorchidism. J Endocrinol Invest 27:760-764
164. Kolon TF, Wiener JS, Lewitton M, Roth DR, Gonzales Jr ET, Lamb DJ 1999 Analysis of homeobox gene HOXA10 mutations in cryptorchidism. J Urol 161:275-280
165. Bertini V, Bertelloni S, Valetto A, Lala R, Foresta C, Simi P 2004 Homeobox HOXA10 gene analysis in cryptorchidism. J Pediatr Endocrinol Metab 17:41-45
166. Layman LC 2007 Hypogonadotropic hypogonadism. Endocrinol Metab Clin North Am 36:283-296
167. Huhtaniemi I, Alevizaki M 2007 Mutations along the hypothalamic-pituitary-gonadal axis affecting male reproduction. Reprod Biomed Online 15:622-632
168. Hortling H, Chapelle A, Johansson CJ, Niemi M, Sulamaa M 1967 An endocrinologic follow-up study of operated cases of cryptorchidism. J Clin Endocrinol Metab 27:120-129
169. Klugo R, Van Dyke DL, Weiss L 1978 Cytogenetic studies of cryptorchid testes. Urology 11:255-256
170. Bartone FF, Schmidt MA 1982 Cryptorchidism: incidence of chromosomal anomalies in 50 cases. J Urol 127:1105-1106
171. Sasagawa I, Nakada T, Ishigooka M, Sawamura T, Adachi Y, Hashimoto T 1996 Chromosomal anomalies in cryptorchidism. Int Urol Nephrol 28:99-102
172. Yamaguchi T, Kitada S, Osada Y 1991 Chromosomal anomalies in cryptorchidism and hypospadias. Urol Int 47:60-63
173. Rohatgi M, Menon PSN, Verma IC, Iyengar JK 1987 The presence of intersexuality in patients with advanced hypospadias and undescended gonads. J Urol 137:263-267
174. McAleer IM, Kaplan GW 2001 Is routine karyotyping necessary in the evaluation of hypospadias and cryptorchidism. J Urol 165: 2029-2031
175. Kaefer M, Diamond D, Hendren WH, Vemulapalli S, Bauer SB, Peters CA, Atala A, Retik AB 1999 The incidence of intersexuality in children with cryptorchidism and hypospadias: stratification based on gonadal palpability and meatal position. J Urol 162:1003-1006
176. Moreno-Garcia M, Miranda EB 2002 Chromosomal anomalies in cryptorchidism and hypospadias. J Urol 168:2170-2172
177. Visootsak J, Graham Jr JM 2006 Klinefelter syndrome and other sex chromosomal aneuploidies. Orphanet J Rare Dis 1:42
178. Nielsen J, Wohlert M 1991 Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arthus, Denmark. In: Evans JA, Hamerton JL, eds. Children and young adults with sex chromosome aneuploidy. Birth defects: Original Article Series. Vol 26. New York: Wiley-Liss, for the March of Dimes Birth Defects Foundation; 209-223
179. Morris JK, Alberman E, Scott C, Jacobs P 2008 Is the prevalence of Klinefelter syndrome increasing? Eur J Hum Genet 16:163-170
180. Caldwell PD, Smith DW 1972 The XXY (Klinefelter's) syndrome in childhood: detection and treatment. J Pediatr 80:250-258
181. Robinson A, Bender B, Linden MG 1991 Summary of clinical findings in children and young adults with sex chromosome anomalies. In: Evans JA, Hamerton JL, eds. Children and young adults with sex chromosome aneuploidy. Birth defects: Original Article Series. Vol 26. New York: Wiley-Liss, for the March of Dimes Birth Defect Foundation; 225-228
182. Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E 2004 Klinefelter's syndrome. Lancet 364:273-283
183. Bojesen A, Gravholt CH 2007 Klinefelter syndrome in clinical practice. Nat Clin Pract Urol 4:192-204
184. Linden MG, Bender BG, Robinson A 1995 Sex chromosome tetrasomy and pentasomy. Pediatrics 96:672-682
185. de la Chapelle A 1981 The etiology of maleness in XX men. Hum Genet 58:105-116
186. Boucekkine C, Toublanc JE, Abbas N, Chaabouni S, Ouahid S, Semrouni M, Jaubert F, Toublanc M, McElreavey K, Vilain E 1994 Clinical and anatomical spectrum in XX sex reversed patients. Relationship to the presence of Y specific DNA-sequences. Clin Endocrinol (Oxf) 40:733-742
187. Dauwerse JG, Hansson KB, Brouwers AA, Peters DJ, Breuning MH 2006 An XX male with the sex-determining region Y gene inserted in the long arm of chromosome 16. Fertil Steril 86: 463.e1-e5
188. de la Chapelle A, Hastbacka J, Korhonen T, Maenpaa J 1990 The etiology of XX sex reversal. Reprod Nutr Dev Suppl 1:39s- 49s
189. Vorona E, Zitzmann M, Gromoll J, Schüring AN, Nieschlag E 2007 Clinical, endocrinological, and epigenetic features of the 46,XX male syndrome, compared with 47,XXY Klinefelter patients. J Clin Endocrinol Metab 92:3458-3465
190. Kobrynski LJ, Sullivan KE 2007 Velocardiofacial syndrome, Di-George syndrome: the chromosome 22q11.2 deletion syndromes. Lancet 370:1443-1452
191. Battaglia A 2005 Del 1p36 syndrome: a newly emerging clinical entity. Brain Dev 27:358-361
192. Enklaar T, Zabel BU, Prawitt D 2006 Beckwith-Wiedemann syndrome: multiple molecular mechanisms. Expert Rev Mol Med 8:1-19
193. Yu H, Patel SB 2005 Recent insights into the Smith-Lemli-Opitz syndrome. Clin Genet 68:383-391
194. Kline AD, Krantz ID, Sommer A, Kliewer M, Jackson LG, Fitz-Patrick DR, Levin AV, Selicorni A 2007 Cornelia de Lange syndrome: clinical review, diagnostic and scoring systems, and anticipatory guidance. Am J Med Genet A 143:1287-1296
195. Chen C, Visootsak J, Dills S, Graham Jr JM 2007 Prader-Willi syndrome: an update and review for the primary pediatrician. Clin Pediatr (Phila) 46:580-591
196. Smith JF, Wayment RO, Cartwright PC, Snow BW, Opitz JM 2007 Genitourinary anomalies of pediatric FG syndrome. J Urol 178: 656-659
197. van der Burgt I 2007 Noonan syndrome. Orphanet J Rare Dis 2:4 198. Antonarakis SE, Epstein CJ 2006 The challenge of Down syndrome. Trends Mol Med 12:473-479
198. Chew G, Hutson JM 2004 Incidence of cryptorchidism and ascending testes in trisomy 21: a 10 year retrospective review. Pediatr Surg Int 20:744-747
199. Graham GE, Allanson JE, Gerritsen JA 2007 Sex chromosome abnormalities. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, eds. Emery and Rimoin's principles and practice of medical genetics. 5th ed. Philadelphia: Churchill Livingstone Elsevier; 1038-1057
200. Nussbaum RL, McInnes RR, Willard HF 2004 Thompson, Thompson genetics in medicine. Revised reprint, 6th ed. Philadelphia: WB Saunders; 172-174
201. Vidaeff AC, Sever LE 2005 In utero exposure to environmental estrogens and male reproductive health: a systematic review of biological and epidemiologic evidence. Reprod Toxicol 20:5-20
202. Giwercman A, Rylander L, Lundberg Giwercman Y 2007 Influence of endocrine disruptors on human male fertility. Reprod Biomed Online 15:633-642
203. Sharpe RM, Skakkebaek NE 1993 Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341:1392-1395
204. Sharpe RM 2003 The 'oestrogen hypothesis' - where do we stand now? Int J Androl 26:2-15
205. Cederroth CR, Schaad O, Descombes P, Chambon P, Vassalli JD, Nef S 2007 Estrogen receptor α is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism. Endocrinology 148:5507-5519
206. Agoulnik AI 2005 Cryptorchidism - an estrogen spoil? J Clin Endocrinol Metab 90:4975-4977
207. Ivell R, Hartung S 2003 The molecular basis of cryptorchidism. Mol Hum Reprod 9:175-181
208. Crisp TM, Clegg ED, Cooper RL, Wood WP, Anderson DG, Baetcke KP, Hoffmann JL, Morrow MS, Rodier DJ, Schaeffer JE, Touart LW, Zeeman MG, Patel YM 1998 Environmental endocrine disruption: an effects assessment and analysis. Environ Health Perspect 106(Suppl 1):11-56
209. Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, Gray Jr LE 2000 The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 58:339-349
210. Melnick R, Lucier G, Wolfe M, Hall R, Stancel G, Prins G, Gallo M, Reuhl K, Ho SM, Brown T, Moore J, Leakey J, Haseman J, Kohn M 2002 Summary of the National Toxicology Program's report of the endocrine disruptors low-dose peer review. Environ Health Perspect 110:427-431
211. Virtanen HE, Tapanainen AE, Kaleva MM, Suomi AM, Main KM, Skakkebaek NE, Toppari J 2006 Mild gestational diabetes as a risk factor for congenital cryptorchidism. J Clin Endocrinol Metab 91:4862-4865
212. Kester MH, Bulduk S, van Toor H, Tibboel D, Meinl W, Glatt H, Falany CN, Coughtrie MW, Schuur AG, Brouwer A, Visser TJ 2002 Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. J Clin Endocrinol Metab 87:1142-1150
213. Kidd KA, Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, Flick RW 2007 Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci USA 104: 8897-8901
214. Vinardi S, Magro P, Manenti M, Lala R, Costantino S, Cortese MG, Canavese F 2001 Testicular function in men treated in childhood for undescended testes. J Pediatr Surg 36:385-388
215. Caroppo E, Niederberger C, Elhanbly S, Schoor R, Ross L, D'Amato G 2005 Effect of cryptorchidism and retractile testes on male factor infertility: a multicenter, retrospective, chart review. Fertil Steril 83:1581-1584
216. Hadziselimovic F, Hocht B, Herzog B, Buser MW 2007 Infertility in cryptorchidism is linked to the stage of germ cell development at orchidopexy. Horm Res 68:46-52
217. Hadziselimovic F 2006 Early successful orchidopexy does not prevent from developing azoospermia. Int Braz J Urol 32:570-573
218. Cortes D, Thorup J, Lindenberg S, Visfeldt J 2003 Infertility despite surgery for cryptorchidism in childhood can be classified by patients with normal or elevated follicle-stimulating hormone and identified at orchidopexy. BJU Int 91:670-674
219. Hadziselimovic F, Herzog B 2001 Importance of early postnatal germ cell maturation for fertility of cryptorchid males. Horm Res 55:6-10
220. Lee PA, O'Leary LA, Songer NJ, Coughlin MT, Bellinger MF, LaPorte RE 1997 Paternity after bilateral cryptorchidism. A controlled study. Arch Pediatr Adolesc Med 151:260-263
221. Lee PA, Coughlin MT 2002 The single testis: paternity after presentation as unilateral cryptorchidism. J Urol 168:1680-1682
222. Hadziselimovic F, Herzog B 2001 The importance of both an early orchidopexy and germ cell maturation for fertility. Lancet 358:1156-1157
223. Cortes D, Thorup JM, Visfeldt J 2001 Cryptorchidism: aspects of fertility and neoplasms.Astudy including data of 1,335 consecutive boys who underwent testicular biopsy simultaneously with surgery for cryptorchidism. Horm Res 55:21-27
224. Pettersson A, Richiardi L, Nordenskjold A, Kaijser M, Akre O 2007 Age at surgery for undescended testis and risk of testicular cancer. N Engl J Med 356:1835-1841
225. Herrinton LJ, Zhao W, Husson G 2003 Management of cryptorchidism and risk of testicular cancer. Am J Epidemiol 157:602-605
226. Nathanson KL, Kanetsky PA, Hawes R, Vaughn DJ, Letrero R, Tucker K, Friedlander M, Phillips KA, Hogg D, Jewett MA, Lohynska R, Daugaard G, Richard S, Chompret A, Bonaïti-Pellié C, Heidenreich A, Olah E, Geczi L, Bodrogi I, Ormiston WJ, Daly PA, Oosterhuis JW, Gillis AJ, Looijenga LH, Guilford P, Fosså SD, Heimdal K, Tjulandin SA, Liubchenko L, Stoll H, Weber W, Rudd M, Huddart R, Crockford GP, Forman D, Oliver DT, Einhorn L, Weber BL, Kramer J, McMaster M, Greene MH, Pike M, Cortessis V, Chen C, Schwartz SM, Bishop DT, Easton DF, Stratton MR, Rapley EA 2005 The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 77:1034-1043
227. Garolla A, Ferlin A, Vinanzi C, Roverato A, Sotti G, Artibani W, Foresta C 2005 Molecular analysis of the androgen receptor gene in testicular cancer. Endocr Relat Cancer 12:645-655
228. Starr JR, Chen C, Doody DR, Hsu L, Ricks S, Weiss NS, Schwartz SM 2005 Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer Epidemiol Biomarkers Prev 14:2183-2190
229. Biermann K, Heukamp LC, Steger K, Zhou H, Franke FE, Guetgemann I, Sonnack V, Brehm R, Berg J, Bastian PJ, Müller SC, Wang-Eckert L, Schorle H, Büttner R 2007 Gene expression profiling identifies new biological markers of neoplastic germ cells. Anticancer Res 27:3091-3100
230. Rajpert-De Meyts E 2006 Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12:303-323
231. Husmann DA 2005 Cryptorchidism and its relationship to testicular neoplasia and microlithiasis. Urology 66:424-426
232. Møller H, Prener A, Skakkebaek NE 1996 Testicular cancer, cryptorchidism, inguinal hernia, testicular atrophy, and genital malformations: case-control studies in Denmark. Cancer Causes Control 7:264-274
233. Walsh TJ, Dall'Era MA, Croughan MS, Carroll PR, Turek PJ 2007 Prepubertal orchiopexy for cryptorchidism may be associated with lower risk of testicular cancer. J Urol 178:1440-1446